





| Catalog No. | HB714016 |
|---|---|
| Description |
Talacotuzumab (HB714016) is a research-grade recombinant antibody targeting CD123. Produced in mammalian cells with native-like glycosylation.
Highlights
|
| Species reactivity | Human |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Host species | Human |
| Isotype | IgG1-kappa |
| Expression system | Mammalian cells |
| Clonality | Monoclonal |
| Target | IL-3R subunit alpha, IL-3 receptor subunit alpha, CD123, Interleukin-3 receptor subunit alpha, IL3R, IL-3R-alpha, IL3RA, IL-3RA |
| Endotoxin level | Please contact the lab for this information. |
| Purity | >95% purity as determined by SDS-PAGE. |
| Purification | Protein A/G purified from cell culture supernatant. |
| Accession | P26951 |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternate Names | CSL-362-AML, CSL362, JNJ-56022473, 1826831-79-1 |
| Background | Interleukin-3 receptor subunit alpha (CD123/IL-3Rα) is a ~43 kDa protein. Cell surface receptor for IL3 expressed on hematopoietic progenitor cells, monocytes and B-lymphocytes that controls the production and differentiation of hematopoietic progenitor cells into lineage-restricted cells. Ligand stimulation rapidly induces hetrodimerization with IL3RB, phosphorylation and enzyme activity of effector proteins such as JAK2 and PI3K that play a role in signaling cell proliferation and differentiation. Activation of JAK2 leads to STAT5-mediated transcriptional program. 1. Huang, S. et al. (1999) Stem cells (Dayton, Ohio) 17, 265-72. PMID: 10527461 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |

Detects CD123/IL3RA in indirect ELISAs.

SDS-PAGE for Research Grade Talacotuzumab.

Western blot analysis was performed using anti-CD123/IL3RA monoclonal antibody at 1μg/ml on various samples.
Lane 1: recombinant human CD123/IL3RA (Catalog No: HB714011), 50ng
Lane 2: recombinant human CD123/IL3RA (Catalog No: HB714011), 30ng
Lane 3: recombinant human CD123/IL3RA (Catalog No: HB714011), 20ng




Contact us for custom quotes, bulk requests and any other issues.
Mail: support@abinScience.com






+86-27-87433958
Building C, No. 666, Shen Dun Si Lu, Wuhan, 430206, China
中文
English
한국어
日本語
Español
Français
Русский